(Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the ...
1d
GlobalData on MSNFDA clears Hologic’s Aptima SARS-CoV-2 assayHologic's Panther system, on which the assay runs, processes the samples, delivering initial outcomes in under three hours.
Coronary artery lesions in patients with SARS-CoV-2 infection more likely to become high-risk plaques. HealthDay News — Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is ...
The following is a summary of “Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: a global systematic review and meta-analysis,” published in ...
SARS-CoV-2 risk is lower among children aged younger than 5 who had vs did not have prior infection, regardless of vaccination status.
Mass cytometry can be used to scale up multiplexed serology testing, as shown for the simultaneous detection of antibody levels against multiple SARS-CoV-2 proteins in hundreds of serum samples.
COVID-19 has little impact on patients with dermatological immune-mediated inflammatory diseases, with effective ...
Objective Delayed second dose SARS-CoV-2 vaccination trades maximal effectiveness for a lower level of immunity across more of the population. We investigated whether patients with inflammatory bowel ...
The virus is related to the pathogen that causes Middle East respiratory syndrome and capitalizes on the same ‘entry receptor ...
Multiple vaccine shots are needed to boost vasculitis patients’ immunity against COVID, especially if they have been treated ...
Some people may remain ill after COVID infection because the virus still lurks in their bodies. The looming question now is: ...
The following is a summary of “60-day mortality and the role of SARS-CoV-2 in hospital admissions of immunocompromised patients during later Omicron period: a population-based study in Sweden,” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results